Thrombus on Mitral Annular Calcification: A Systematic Review of Management and Outcomes

Amber Cintosun1, David Belzile2, Maala Sooriyakanthan2

  • 1Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

CJC Open
|December 30, 2024
PubMed
Abstract

Insights

Thrombus formation on mitral annular calcification (MAC) is rare but increases thromboembolic risk. Most patients with MAC thrombus are managed with anticoagulation, though some require surgery, and persistent thrombus or embolization can occur.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Thrombosis

Background:

  • Mitral annular calcification (MAC) is a common degenerative process affecting the mitral valve.
  • Thrombus formation on MAC is a rare but significant complication, increasing the risk of thromboembolic events.
  • Current understanding of outcomes and management strategies for MAC thrombus is limited.

Purpose of the Study:

  • To conduct a systematic review describing the management and outcomes of patients with thrombus on MAC.
  • To identify treatment strategies and associated clinical events in this patient population.

Main Methods:

  • Systematic search of MEDLINE, Embase, and Cochrane databases.
  • Inclusion of studies reporting on patients with thrombus on MAC, excluding those with prior valve intervention or prosthesis.
  • Primary outcome assessment included treatment, mortality, and thromboembolic events.

Main Results:

  • The review included 15 studies with 22 cases; most patients were female and presented with stroke, transient ischemic event, or myocardial infarction.
  • The majority of patients (77%) were treated with anticoagulation alone; 23% required surgery, often for recurrent embolization.
  • No mortality was reported, but 27% experienced post-diagnosis thromboembolic events, and 23% on anticoagulation alone had persistent thrombus.

Conclusions:

  • Patients with MAC presenting with thromboembolic events require echocardiographic assessment for thrombus.
  • While anticoagulation is often sufficient, a notable proportion of patients necessitate surgical intervention.
  • Persistent thrombus and recurrent embolization are common, highlighting the need for further research into optimal long-term management.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...